Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR
Dilip Narayanan, Osman ABSM Gani, Franz XE Gruber, Richard A Engh
2Citations
(Scopus)
100Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR'. Together they form a unique fingerprint.